SINTX Regains Nasdaq Compliance, Removing Delisting Overhang
SINT is trading near its 52-week low of $1.4 (12% above the low) on elevated volume (2.8× avg).
Summary
SINTX has regained compliance with Nasdaq's stockholders' equity requirement, resolving the delisting notice issued in May. This removes a major overhang for the stock, which had been trading under the threat of removal. The company had been actively raising capital through private placements and warrant restructurings to shore up equity. With compliance restored, the immediate delisting risk is off the table, though the company's going concern doubts and cash burn remain key concerns. Watch for any subsequent 424B filings from the S-3 shelf to gauge further dilution.
At the time of this announcement, SINT was trading at $1.57 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.5M. The 52-week trading range was $1.40 to $6.78. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.